Thanks to everyone who made this year’s Trans-Pacific Health Sciences Dialogue such a great success. We are grateful for the contributions of our attendees, speakers and sponsors that made this such a special event.
See you next year in Boston
Coming Soon: Gallery of Photos from the 2014 Trans-Pacific Health Sciences Dialogue
About the Conference
The Trans-Pacific Health Sciences Dialogue is a C-level meeting for biopharmaceutical industry executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America. This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an invitation-only event for Asian and North American senior biopharmaceutical executives, KOLs and select professional industry advisors, service providers and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment. To request an invitation, please contact Lawrence Joseph.
Industry News from BioCentury
- Synergy raises $175M in note dealSynergy Pharmaceuticals Inc. (NASDAQ:SGYP) raised $175 million through the sale of senior unsecured convertible notes. The notes bear 7.5% interest, mature in 2019 and initially convert at $3.11.
Synergy's lead compound is plecanatide, a guanylate cyclase C (GCC; GUCY2C) agonist that is in two Phase III trials for chronic idiopathic constipation.
Synergy was up $0.31 (10%) to $3.42 on Wednesday.
Industry News from PharmAsia
- Pfizer Joins Forces With SinoPharm To Infiltrate China County Hospital MarketAs China showers billions of dollars into grassroots medical facilities, Pfizer has taken note and used its learning from a previously unsuccessful bid to penetrate the huge, but vastly challenging country hospital market.<img src="http://feeds.feedburner.com/~r/_PharmAsiaNews/~4/x597hRgL734" height="1" width="1" />
Upcoming Supporter Events
Life Science Future
October 13-14, 2014
Sheraton Downtown Hotel